Stay updated on Pilot Trial Flecainide in ARVC Patients Clinical Trial
Sign up to get notified when there's something new on the Pilot Trial Flecainide in ARVC Patients Clinical Trial page.

Latest updates to the Pilot Trial Flecainide in ARVC Patients Clinical Trial page
- Check5 days agoChange DetectedThe page shows a revision update from v3.6.0 to v3.6.2, indicating a backend/software update with no substantive changes to the study details displayed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRecruitment status now shows 'No longer looking for participants', clarifying that the study is not currently enrolling. New help and navigation sections — 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' — have been added, and the Intervention/Treatment heading formatting was adjusted, accompanied by the page revision note 'Revision: v3.6.0'.SummaryDifference0.4%

- Check27 days agoChange DetectedA new revision marker 'Revision: v3.5.5' appears on the page, replacing the previous 'Revision: v3.5.4', indicating a small platform update to the page metadata. This change does not alter the study details or other substantive content.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page shows a new revision tag, updating from v3.5.3 to v3.5.4, indicating a small version update with no visible changes to the study information.SummaryDifference0.1%

- Check48 days agoChange DetectedA new bibliographic citation with an author name was added to the Publications section, and notes clarify that the content is sourced from PubMed.SummaryDifference0.2%

- Check63 days agoChange DetectedRevision: v3.5.3 updates the page from v3.5.2 to v3.5.3. This represents a minor version update to the site documentation.SummaryDifference0.1%

Stay in the know with updates to Pilot Trial Flecainide in ARVC Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pilot Trial Flecainide in ARVC Patients Clinical Trial page.